|
|
|
|
 |
|||
|
|||
Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein
F Thiebaut, T Tsuruo, H Hamada, MM Gottesman, I Pastan and MC Willingham
Laboratory of Molecular Biology, National Cancer Institute, Bethesda, Maryland 20892.
Using peroxidase immunohistochemistry, we examined the distribution of P170, a multidrug transport protein, in normal tissues by use of two different monoclonal antibodies (MAb). MAb MRK16 is a MAb that has been shown to react with an epitope in P170 located on the external face of the plasma membrane of multidrug-resistant human cells. MAb C219 has been shown to react with P170 in many mammalian species, and detects an epitope located on the cytoplasmic face of the plasma membrane. Using MRK16, we have previously described the localization of P170 on the bile canalicular face of hepatocytes, the apical surface of proximal tubular cells in kidney, and the surface epithelium in the lower GI tract in normal human tissues. In this work, we report that MRK16 also detects P170 in the capillaries of some human brain samples. A similar pattern was found using MAb C219 in rat tissues. in addition, MAb C219 showed intense localization in selected skeletal muscle fibers and all cardiac muscle fibers in rat and human tissues. ATPase cytochemistry showed that these reactive skeletal muscle fibers were of the type I (slow-twitch) class. Other additional sites of C219 reactivity in rat tissues were found in pancreatic acini, seminal vesicle, and testis. Electrophoretic gel immunoblotting showed two protein bands reactive with MAb C219. In liver, MAb C219 reacted with a approximately 170 KD band. In skeletal and cardiac muscle, MAb C219 reacted with a approximately 200 KD band which migrated in the same position as myosin. This band also reacted with an antibody to skeletal muscle myosin. This result suggests that C219 may crossreact with the heavy chain of muscle myosin in cardiac and skeletal muscle. Because MAb C219 reacts with proteins other than P170, it should be used with caution in studies of multidrug resistance.
Volume 37,
Issue 2,
pp. 159-164,
02/01/1989
Copyright © 1989 by The Histochemical Society
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  L. Couture, J. A. Nash, and J. Turgeon The ATP-Binding Cassette Transporters and Their Implication in Drug Disposition: A Special Look at the Heart. Pharmacol. Rev., June 1, 2006; 58(2): 244 - 258. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Song, J. K. Lamba, L. Zhang, E. Schuetz, N. Shukla, B. Meibohm, and C. R. Yates G2677T and C3435T Genotype and Haplotype Are Associated With Hepatic ABCB1 (MDR1) Expression. J. Clin. Pharmacol., March 1, 2006; 46(3): 373 - 379. [Full Text] [PDF]
|
|
|
|
 |
|
 H. A. Volk and W. Loscher Multidrug resistance in epilepsy: rats with drug-resistant seizures exhibit enhanced brain expression of P-glycoprotein compared with rats with drug-responsive seizures Brain, June 1, 2005; 128(6): 1358 - 1368. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Volk, H. Potschka, and W. Loscher Immunohistochemical Localization of P-glycoprotein in Rat Brain and Detection of Its Increased Expression by Seizures Are Sensitive to Fixation and Staining Variables J. Histochem. Cytochem., April 1, 2005; 53(4): 517 - 531. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Bauer, A. M. S. Hartz, G. Fricker, and D. S. Miller Modulation of p-Glycoprotein Transport Function at the Blood-Brain Barrier Experimental Biology and Medicine, February 1, 2005; 230(2): 118 - 127. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Uhr, C. Namendorf, M. T. Grauer, M. Rosenhagen, and M. Ebinger P-glycoprotein is a factor in the uptake of dextromethorphan, but not of melperone, into the mouse brain: evidence for an overlap in substrate specificity between P-gp and CYP2D6 J Psychopharmacol, December 1, 2004; 18(4): 509 - 515. [Abstract] [PDF]
|
|
|
|
 |
|
 S. U. C. Sankatsing, J. H. Beijnen, A. H. Schinkel, J. M. A. Lange, and J. M. Prins P Glycoprotein in Human Immunodeficiency Virus Type 1 Infection and Therapy Antimicrob. Agents Chemother., April 1, 2004; 48(4): 1073 - 1081. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Geromin, J.-F. Bourge, A. Soulie, R. Pawliuk, C. Fleet, E. Michel, Y. Denizot, C. Berthou, P. Leboulch, F. Sigaux, et al. Glycoprotein 170 Induces Platelet-Activating Factor Receptor Membrane Expression and Confers Tumor Cell Hypersensitivity to NK-Dependent Cell Lysis J. Immunol., March 15, 2004; 172(6): 3604 - 3611. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Taniguchi, Y. Mochida, T. Uchiumi, T. Tahira, K. Hayashi, K. Takagi, M. Shimada, Y. Maehara, H. Kuwano, S. Kono, et al. Genetic polymorphism at the 5' regulatory region of multidrug resistance 1 (MDR1) and its association with interindividual variation of expression level in the colon Mol. Cancer Ther., December 1, 2003; 2(12): 1351 - 1359. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Woodland, G. Koren, and S. Ito From Bench to Bedside: Utilization of an In Vitro Model to Predict Potential Drug-Drug Interactions in the Kidney: The Digoxin-Mifepristone Example J. Clin. Pharmacol., July 1, 2003; 43(7): 743 - 750. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Imbert, M. Jardin, C. Fernandez, J. C. Gantier, F. Dromer, G. Baron, F. Mentre, L. van Beijsterveldt, E. Singlas, and F. Gimenez Effect of Efflux Inhibition on Brain Uptake of Itraconazole in Mice Infected with Cryptococcus neoformans Drug Metab. Dispos., March 1, 2003; 31(3): 319 - 325. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Dai, P. Marbach, M. Lemaire, M. Hayes, and W. F. Elmquist Distribution of STI-571 to the Brain Is Limited by P-Glycoprotein-Mediated Efflux J. Pharmacol. Exp. Ther., March 1, 2003; 304(3): 1085 - 1092. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Kimchi-Sarfaty, J. J. Gribar, and M. M. Gottesman Functional Characterization of Coding Polymorphisms in the Human MDR1 Gene Using a Vaccinia Virus Expression System Mol. Pharmacol., July 1, 2002; 62(1): 1 - 6. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Lee, S. Dallas, M. Hong, and R. Bendayan Drug Transporters in the Central Nervous System: Brain Barriers and Brain Parenchyma Considerations Pharmacol. Rev., December 1, 2001; 53(4): 569 - 596. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S. Miller Nucleoside Phosphonate Interactions with Multiple Organic Anion Transporters in Renal Proximal Tubule J. Pharmacol. Exp. Ther., November 1, 2001; 299(2): 567 - 574. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Sturm, C. Ziemann, K. I. Hirsch-Ernst, and H. Segner Expression and functional activity of P-glycoprotein in cultured hepatocytes from Oncorhynchus mykiss Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2001; 281(4): R1119 - R1126. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Karssen, O. C. Meijer, I. C. J. van der Sandt, P. J. Lucassen, E. C. M. de Lange, A. G. de Boer, and E. R. de Kloet Multidrug Resistance P-Glycoprotein Hampers the Access of Cortisol But Not of Corticosterone to Mouse and Human Brain Endocrinology, June 1, 2001; 142(6): 2686 - 2694. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-H. Han, D. H. Sweet, D.-N. Hu, and J. B. Pritchard Characterization of a Novel Cationic Drug Transporter in Human Retinal Pigment Epithelial Cells J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 450 - 457. [Abstract] [Full Text]
|
|
|
|
|
|
C. Wandel, R. B. Kim, F. P. Guengerich, and A. J. J. Wood Mibefradil Is a P-Glycoprotein Substrate and a Potent Inhibitor of Both P-Glycoprotein and CYP3A In Vitro Drug Metab. Dispos., August 1, 2000; 28(8): 895 - 898. [Abstract] [Full Text]
|
|
|
|
|
|
C. Tanaka, R. Kawai, and M. Rowland Dose-Dependent Pharmacokinetics of Cyclosporin A in Rats: Events in Tissues Drug Metab. Dispos., May 1, 2000; 28(5): 582 - 589. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. W. Loo and D. M. Clarke The Packing of the Transmembrane Segments of Human Multidrug Resistance P-glycoprotein Is Revealed by Disulfide Cross-linking Analysis J. Biol. Chem., February 25, 2000; 275(8): 5253 - 5256. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. H. van den Elsen, D. A. Kuntz, F. J. Hoedemaeker, and D. R. Rose Antibody C219 recognizes an alpha -helical epitope on P-glycoprotein PNAS, November 23, 1999; 96(24): 13679 - 13684. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Willingham Conditional Epitopes: Is Your Antibody Always Specific? J. Histochem. Cytochem., October 1, 1999; 47(10): 1233 - 1236. [Full Text]
|
|
|
|
 |
|
 C. Wandel, R. B. Kim, S. Kajiji, F. P. Guengerich, G. R. Wilkinson, and A. J. J. Wood P-Glycoprotein and Cytochrome P-450 3A Inhibition: Dissociation of Inhibitory Potencies Cancer Res., August 1, 1999; 59(16): 3944 - 3948. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Murata, I. Tamai, H. Kato, O. Nagata, H. Kato, and A. Tsuji Efflux Transport of a New Quinolone Antibacterial Agent, HSR-903, across the Blood-Brain Barrier J. Pharmacol. Exp. Ther., July 1, 1999; 290(1): 51 - 57. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. W. Johnstone, E. Cretney, and M. J. Smyth P-Glycoprotein Protects Leukemia Cells Against Caspase-Dependent, but not Caspase-Independent, Cell Death Blood, February 1, 1999; 93(3): 1075 - 1085. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Egashira, N. Kawamata, K. Sugimoto, T. Kaneko, and K. Oshimi P-Glycoprotein Expression on Normal and Abnormally Expanded Natural Killer Cells and Inhibition of P-Glycoprotein Function by Cyclosporin A and Its Analogue, PSC833 Blood, January 15, 1999; 93(2): 599 - 606. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Collett, N. B. Higgs, E. Sims, M. Rowl, and a. G. Warhurst Modulation of the Permeability of H2 Receptor Antagonists Cimetidine and Ranitidine by P-Glycoprotein in Rat Intestine and the Human Colonic Cell Line Caco-2 J. Pharmacol. Exp. Ther., January 1, 1999; 288(1): 171 - 178. [Abstract] [Full Text]
|
|
|
|
|
|
D. E. Burgio, M. P. Gosl, and a. P. J. McNamara Effects of P-glycoprotein Modulators on Etoposide Elimination and Central Nervous System Distribution J. Pharmacol. Exp. Ther., December 1, 1998; 287(3): 911 - 917. [Abstract] [Full Text]
|
|
|
|
|
|
A. E. Kim, J. M. Dintaman, D. S. Waddell, and J. A. Silverman Saquinavir, an HIV Protease Inhibitor, Is Transported by P-Glycoprotein J. Pharmacol. Exp. Ther., September 1, 1998; 286(3): 1439 - 1445. [Abstract] [Full Text]
|
|
|
|
|
|
A. Venditti, G. Del Poeta, F. Buccisano, A. Tamburini, M. Christina Cox-Froncillo, A. Bruno, B. Del Moro, A. Maria Epiceno, M. Masi, S. Amadori, et al. Biological Features of Acute Myeloid Leukemia in the Elderly Blood, July 15, 1998; 92(2): 697 - 699. [Full Text] [PDF]
|
|
|
|
|
|
G. Decorti, I. Peloso, D. Favarin, F. B. Klugmann, L. Candussio, E. Crivellato, F. Mallardi, and L. Baldini Handling of Doxorubicin by the LLC-PK1 Kidney Epithelial Cell Line J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 525 - 530. [Abstract] [Full Text]
|
|
|
|
|
|
S. Desrayaud, E. C. M. De Lange, M. Lemaire, A. Bruelisauer, A. G. De Boer, and D. D. Breimer Effect of the Mdr1a P-Glycoprotein Gene Disruption on the Tissue Distribution of SDZ PSC 833, a Multidrug Resistance-Reversing Agent, in Mice J. Pharmacol. Exp. Ther., May 1, 1998; 285(2): 438 - 443. [Abstract] [Full Text]
|
|
|
|
|
|
M. Arboix, O. G. Paz, T. Colombo, and M. D'Incalci J. Pharmacol. Exp. Ther., June 1, 1997; 281(3): 1226 - 1230. [Abstract] [Full Text]
|
|
|
|
|
|
A. Sparreboom, J. van Asperen, U. Mayer, A. H. Schinkel, J. W. Smit, D. K. F. Meijer, P. Borst, W. J. Nooijen, J. H. Beijnen, and O. van Tellingen Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine PNAS, March 4, 1997; 94(5): 2031 - 2035. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.M. Gottesman, S.V. Ambudkar, B. Ni, J.M. Aran, Y. Sugimoto, C.O. Cardarelli, and I. Pastan Exploiting Multidrug Resistance to Treat Cancer Cold Spring Harb Symp Quant Biol, January 1, 1994; 59(0): 677 - 683. [Abstract] [PDF]
|
|
|
|
 |
|
 Z. P. Pavelic, J. Reising, L. Pavelic, D. J. Kelley, P. J. Stambrook, and J. L. Gluckman Detection of P-Glycoprotein With Four Monoclonal Antibodies in Normal and Tumor Tissues Arch Otolaryngol Head Neck Surg, July 1, 1993; 119(7): 753 - 757. [Abstract] [PDF]
|
|
|
|
 |
|
 K. Chin, K Ueda, I Pastan, and M. Gottesman Modulation of activity of the promoter of the human MDR1 gene by Ras and p53 Science, January 24, 1992; 255(5043): 459 - 462. [Abstract] [PDF]
|
|
|
|
|
|
A. Geick, M. Eichelbaum, and O. Burk Nuclear Receptor Response Elements Mediate Induction of Intestinal MDR1 by Rifampin J. Biol. Chem., April 27, 2001; 276(18): 14581 - 14587. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Hoffmeyer, O. Burk, O. von Richter, H. P. Arnold, J. Brockmoller, A. Johne, I. Cascorbi, T. Gerloff, I. Roots, M. Eichelbaum, et al. Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo PNAS, March 28, 2000; 97(7): 3473 - 3478. [Abstract] [Full Text] [PDF]
|
|
| Guidelines | Subscriptions | About | exPRESS - Current - Archive | Business Information | Contact |